Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling -- Ignore unavailable to you. Want to Upgrade?

To: Harpo who wrote (5270)	8/17/2001 9:59:05 PM
From: Oak Tree	Respond to of 6873

I am sorry to hear you have lost friends to H&N cancer. My comment intent however was to comment on how little this company had going for it aside from some hype and over-enthusiasm for the EGFR inhibitors in general. Odds are they have less effect than antiangiogenics, which so far have been a bust. Unfortunately I think this stock is a bust. It is worth mentioning that among people who do not abuse alcohol and tobacco who get head and neck cancers, cures are very common. Sorry for my comment.